Journal Article

Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes

Gail E. Herman

in Human Molecular Genetics

Volume 12, issue suppl_1, pages R75-R88
Published in print April 2003 | ISSN: 0964-6906
Published online April 2003 | e-ISSN: 1460-2083 | DOI:
Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes

Show Summary Details


Since 1998, five disorders involving enzyme defects in post-squalene cholesterol biosynthesis have been identified—desmosterolosis, X-linked dominant chondrodysplasia punctata, CHILD syndrome, lathosterolosis, and hydrops-ectopic calcification-moth-eaten skeletal dysplasia. They join the most common cholesterol biosynthetic disorder, Smith–Lemli–Opitz syndrome, whose underlying defect was identified in 1993. All are associated with major developmental malformations that are unusual for metabolic disorders. The existence of mouse models for five of these disorders is beginning to enable more detailed developmental and in vitro studies examining the mechanisms involved in disease pathogenesis. In this review, an overview of the cholesterol biosynthetic pathway will be presented. Clinical features of the human disorders and mouse models of post-squalene cholesterol biosynthesis will then be discussed.

Journal Article.  10735 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.